Research Specifications
- Sequence:
- Gln-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
- CAS:
- 1208243-50-8
- Molecular weight:
- 1257.32 Da
- Vial:
- 10mg lyophilized
- Purity:
- ≥98% HPLC verified
ARA-290 10mg
Cibinetide 11-amino-acid EPO derivative
CAS: 1112912-22-1
11 aa
Length
EPO helix B fragment
No
Erythropoiesis
IRR vs EPO-R homodimer
IRR
Target receptor
Brines 2008
$80.99In Stock
Buy Now ≥98% Purity Verified Free Shipping $200+ HPLC Tested
Phase 2
Phase 2 trials for small fiber neuropathy
Developed by Araim Pharmaceuticals. Multiple Phase 2 trials completed; no Phase 3 initiated as of 2024. Not FDA-approved.
Also Known As
ARA 290CibinetideEPO Helix B Surface PeptideHBSPPHBSP
Reconstitution & Dosing Guide
BAC Water
2mL
Final Concentration
5 mg/mL
Per Dose
4 mg (Phase 2) = 0.8 mL · 2 mg = 0.4 mL
Research protocols typically dose daily or every other day
Often Stacked With
Published References
- 1.Brines M, Patel NSA, Villa P, et al.. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci USA (2008) PMID: 18678912
- 2.Dahan A, Dunne A, Swartjes M, et al.. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss. Molecular Medicine (2013) PMID: 23616966
Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.
Price Comparison
| Supplier | Purity | Price | Shipping |
|---|---|---|---|
| our verified supplier | >98% HPLC | $80.99 | Free over $200 |
| Generic Research Suppliers | Varies (often <95%) | Similar–Higher | Varies |
| Pharmaceutical (Rx only) | Pharmaceutical grade | Not available for research | Rx required |
Buy Peptides Compounds
AICAR 50mg
$62.99Buy Now
Abaloparatide 3mg
$134.99Buy Now
Cartalax 20mg
$71.99Buy Now
Glutathione 1500mg
$161.99Buy Now
ARA-290 10mg
$80.99